Canadian Biomaterials Society
La Société Canadienne des Biomatériaux

Dear CBS Members, As you are aware, the COVID-19 pandemic has caused numerous disruptions around the world, and scheduled conferences are being either postponed or canceled...

We are very pleased to inform you that Dr. Paul Santerre has been selected by the Board of Directors of the Canadian Biomaterials Society CBS as the next recipient of the CBS Lifetime Achievement Award , acknowledging his outstanding contributions to our Society...

CBS is pleased to offer travel awards to assist students and post-doctoral fellows who are CBS members to present their accepted oral or poster abstracts at the 11th World Biomaterials Congress this May in Glasgow, Scotland...

The Fall 2019 edition of the CBS Newsletter is now available. Read about the latest initiatives from CBS, look back at the Quebec City CBS Annual Meeting and look ahead to WBC 2020 coming up this May in Glasgow, find out more about our very active student chapters across the country, meet the new CBS Senior Board Members and President-Elect, and learn more about the many award opportunities provided by CBS...

Systemic adoptive T lymphocyte transfer is an emerging cancer immunotherapy showing tremendous promise in clinical studies, and its success lies in the ability of the antigen-experienced cytotoxic T lymphocytes cTL to access and to persist in the tumour microenvironment 1 ...

Most strategies aiming at developing biocompatible arterial prostheses target the recruitment of endothelial cells EC to reproduce a native artery intima...

The muscle tissues in human body, including cardiac muscle and skeletal muscle, play the vital role in maintaining life and human body motion...

In recent years, biomaterials have helped literally shape conduits, barriers, and tools inside of the body...

Doxorubicin is widespread and influential apoptosis-inducing drug in cancer chemotherapy which interdicts DNA replication and treats different types of cancers including, benign, potentially-malignant, glioblastoma malignant tumours 1 2 3 ...